Cargando…

Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35

Correction for ‘Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35’ by Mengying Wei et al., RSC Adv., 2019, 9, 18308–18319. DOI: 10.1039/C9RA00302A.

Detalles Bibliográficos
Autores principales:	Wei, Mengying, Liu, Yuanyuan, Pi, Zifeng, Yue, Kexin, Li, Shizhe, Hu, Mingxin, Liu, Zhiqiang, Song, Fengrui, Liu, Zhongying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695072/ https://www.ncbi.nlm.nih.gov/pubmed/35426990 http://dx.doi.org/10.1039/d1ra90081a

Ejemplares similares

Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35
por: Wei, Mengying, et al.
Publicado: (2019)

Systematically Characterize the Anti-Alzheimer’s Disease Mechanism of Lignans from S. chinensis Based on In-Vivo Ingredient Analysis and Target-Network Pharmacology Strategy by UHPLC–Q-TOF-MS
por: Wei, Mengying, et al.
Publicado: (2019)

Metabolomics analysis of multidrug-resistant breast cancer cells in vitro using methyl-tert-butyl ether method
por: Zong, Li, et al.
Publicado: (2018)

Targeted metabolome profiling by dual-probe microdialysis sampling and treatment using Gardenia jasminoides for rats with type 2 diabetes
por: Wang, Lu, et al.
Publicado: (2017)

Protective effects of Dendrobium nobile Lindl. alkaloids on amyloid beta (25–35)-induced neuronal injury
por: Zhang, Wei, et al.
Publicado: (2017)

Cirsium japonicum var. Maackii Improves Cognitive Impairment under Amyloid Beta(25-35)-Induced Alzheimer's Disease Model
por: Pang, Qi Qi, et al.
Publicado: (2022)

Oxidation of Methionine-35 in Alzheimer’s amyloid-beta peptide and the aggregation of the oxidized peptide
por: Friedemann, Merlin, et al.
Publicado: (2015)

Trace determination and characterization of ginsenosides in rat plasma through magnetic dispersive solid-phase extraction based on core-shell polydopamine-coated magnetic nanoparticles
por: Zhao, Ningning, et al.
Publicado: (2020)

Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer’s Beta-Amyloid Peptide (25–35) and Cholinesterase Inhibitory Property of Its Bioactive Compounds
por: Shanmuganathan, Balakrishnan, et al.
Publicado: (2015)

Exploring the potential pharmacodynamic material basis and pharmacologic mechanism of the Fufang-Xialian-Capsule in chronic atrophic gastritis by network pharmacology approach based on the components absorbed into the blood
por: Li, Shizhe, et al.
Publicado: (2018)

Amyloid-beta peptide (25–35) triggers a reorganization of lipid membranes driven by temperature changes
por: Ivankov, Oleksandr, et al.
Publicado: (2021)

Protective effects of Populus tomentiglandulosa against cognitive impairment by regulating oxidative stress in an amyloid beta(25–35)-induced Alzheimer's disease mouse model
por: Kwon, Yu Ri, et al.
Publicado: (2022)

Effects of the fermented Zizyphus jujuba in the amyloid β(25-35)-induced Alzheimer's disease mouse model
por: Kim, Min Jeong, et al.
Publicado: (2021)

Regulation of adenosine triphosphate-sensitive potassium channels suppresses the toxic effects of amyloid-beta peptide (25–35)
por: Kong, Min, et al.
Publicado: (2013)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
por: Luo, Ziyi, et al.
Publicado: (2021)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Scutellaria baicalensis stem-leaf total flavonoid reduces neuronal apoptosis induced by amyloid beta-peptide (25–35)☆
por: Wang, Ruiting, et al.
Publicado: (2013)

Role of Notch-1 signaling pathway in PC12 cell apoptosis induced by amyloid beta-peptide (25–35)
por: Liang, Huimin, et al.
Publicado: (2014)

Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects☆
por: Xi, Feifei, et al.
Publicado: (2012)

Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta(25–35) via the Autophagy Pathway
por: Xu, Pengjuan, et al.
Publicado: (2015)

Putative multiple reaction monitoring strategy for the comparative pharmacokinetics of postoral administration Renshen–Yuanzhi compatibility through liquid chromatography–tandem mass spectrometry
por: Sun, Yufei, et al.
Publicado: (2020)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

Protective Effects of Cirsium japonicum var. maackii Flower on Amyloid Beta(25–35)-Treated C6 Glial Cells
por: Pang, Qi Qi, et al.
Publicado: (2023)

Carnitine palmitoyltransferase 1 (CPT1) alleviates oxidative stress and apoptosis of hippocampal neuron in response to beta-Amyloid peptide fragment Aβ(25-35)
por: Ding, Yiyun, et al.
Publicado: (2021)

The amyloid hypothesis of Alzheimer's disease at 25 years
por: Selkoe, Dennis J, et al.
Publicado: (2016)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

Nanostructural Differentiation and Toxicity of Amyloid-β25-35 Aggregates Ensue from Distinct Secondary Conformation
por: Song, Yongxiu, et al.
Publicado: (2018)

The neurotransmitter serotonin interrupts α-synuclein amyloid maturation
por: Falsone, S. Fabio, et al.
Publicado: (2011)

Therapeutic value of the metabolomic active neurotransmitter isorhynchophylline in the treatment of spontaneously hypertensive rats by regulating neurotransmitters
por: Alharbi, Homood, et al.
Publicado: (2021)

Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
por: Yang, Zhenqi, et al.
Publicado: (2023)

(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis
por: Fagiani, Francesca, et al.
Publicado: (2021)

SIRT1 Is Involved in the Neuroprotection of Pterostilbene Against Amyloid β 25–35-Induced Cognitive Deficits in Mice
por: Zhu, Lin, et al.
Publicado: (2022)

Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an aβ(25-35)-induced rat model of Alzheimer’s disease
por: Li, Hongli, et al.
Publicado: (2022)

The amyloid beta ion channel hypothesis of Alzheimer’s disease
por: Shirwany, Najeeb A, et al.
Publicado: (2007)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
por: Wildburger, Norelle C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_137k47fdh7qn3n6paco4jftmom